BEIJING: China's drug regulator said it has launched a nationwide inspection of vaccine production as authorities step up the response to a fraud case that has re-ignited public fears over the safety of the country's medicines.

The State Drug Administration (SDA) said in an announcement issued late Wednesday that it had dispatched inspection teams 'to thoroughly investigate the whole process and entire chain of vaccine production of all vaccine producers'.